Novartis could have a U.S. deal that shields it from tariffs, CEO tells CNBC

The continent's pharma sector could be one of its worst hit by Trump's latest tariffs on some European countries.

By CNBC · CNBC

The continent's pharma sector could be one of its worst hit by Trump's latest tariffs on some European countries.